CDD Senior / Principal Scientist
admin@pathologynews.com2024-08-12T07:48:47+00:00Paris - Remote France
August 2024
Head of Frontier Research
admin@pathologynews.com2024-08-12T07:43:46+00:00Paris - Nantes - London - Remote R&Tech
Implementation Engineer, North America
admin@pathologynews.com2024-08-09T16:52:54+00:00Operations · Philadelphia, Pennsylvania (Hybrid)
General Application – Join Us!
admin@pathologynews.com2024-08-09T16:42:31+00:00General · Philadelphia, Pennsylvania (Hybrid)
Sales Director, Clinical, US West
admin@pathologynews.com2024-08-09T16:35:22+00:00Commercial · Remote
Senior Principal R&D Scientist- CDx
admin@pathologynews.com2024-08-09T10:12:52+00:00The Senior Principal Research and Development Scientist is critical to the development of immunochemistry and growth of complex advanced staining assays to drive clinical content. Providing strategic direction to inform our R&D efforts, driving innovation and creation of novel diagnostics assays and platforms to support precision medicine initiatives, positioning Leica Biosystems (LBS) as a leading-edge cancer diagnostics pharma partner.
Unlocking the Complexities of Cancer: Paige Launches World’s Largest AI Models to Revolutionize Cancer Diagnosis with Second Generation of Virchow
admin@pathologynews.com2024-08-08T12:00:29+00:00Virchow’s scale is greater than any other pathology foundation model: Trained on 3 million pathology slides; from more than 40 different tissue types; Built on 1.8 billion parameters
Case Of The Month | August 2024 | Canine Facial Eosinophilic Folliculitis and Furunculosis in a 2 Years Old, Female German Shepherd Dog
admin@pathologynews.com2025-07-28T12:42:07+00:00Canine facial eosinophilic folliculitis and furunculosis is an acute, generally self-limiting inflammatory condition. Although its exact pathogenesis is not known, the good response to corticosteroids suggests a hypersensitivity mediated pathogenesis, where insect stings or spider bites are suspected to be triggering factors.
Deep Bio’s AI Model for Prostate Cancer Assessment Validated by Researchers
admin@pathologynews.com2024-08-06T14:58:26+00:00Deep Bio Inc., a leader in AI-driven digital pathology solutions, announced the publication of an external validation study for its DeepDx Prostate AI algorithm, conducted by Stanford Medicine. The study, titled “External Validation of an Artificial Intelligence Model for Gleason Grading of Prostate Cancer on Prostatectomy Specimens,” was published in the British Journal of Urology International.
